Concordia International Corp. (TSE:CXR – Get Free Report) (NASDAQ:CXRX)’s share price traded down 1.5% during trading on Monday . The stock traded as low as C$25.01 and last traded at C$25.04. 73,541 shares traded hands during mid-day trading, an increase of 1,714% from the average session volume of 4,054 shares. The stock had previously closed at C$25.43.
Concordia International Stock Down 1.5 %
The company has a quick ratio of 1.66, a current ratio of 2.10 and a debt-to-equity ratio of 457.02. The company has a 50 day simple moving average of C$25.04. The company has a market cap of C$1.22 billion and a price-to-earnings ratio of 0.07.
About Concordia International
Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.
Featured Articles
- Five stocks we like better than Concordia International
- 3 Monster Growth Stocks to Buy Now
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Overbought Stocks Explained: Should You Trade Them?
- 3 Value Stocks You Can Buy Before They Become Big
- How to Most Effectively Use the MarketBeat Earnings Screener
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.
